PD II Flashcards
Freezing of Gait Questionnaire
- 6-item questionnaire to be completed during “on” state
- Each item scored 0 (absence of sis) to 4 (most severe)
- Max score is 24
- Answers based on past week or overall presence of freezing that entire day
Levodopa-carbidopa and dyskinesia
Abnormal involuntary movements that usually occur at peak dose + increases in intensity with increased time on dose
Deep brain stimulation benefits
- Minimizes “off” time
- May be able to reduce medication dosage
FES benefits
- Improvements in UPDRS
- Maintained improvements in rigidity and bradykinesia 4 weeks after FES cessation
LSVT benefits
Improved TUG, UPDRS, gait speed
Anticholinergics brand names
- Artane
- Cogentin
Mini-BESTest
- 14 item test
- Each item scored 0 (severe impairment) to 2 (normal)
- Max score is 28
- Cut-off score: <23/28 consistent with increased risk of falling
Side effects of levadopa-carbidopa
- Nausea
- Drowsy
- OH
- Dyskinesia
- Hallucinations
Therapeutic windo of levadopa-carbidopa
- Over time, the duration target clinical response (therapeutic window) narrows/shortens
BESTest
- 36 item test
- Each item scored 0 (severe impairment) to 3 (normal)
- Max score is 108
- Cut-off score: <69% indicates risk of falling
Criteria for DBS
- Idiopathic PD
- Intact cognition
- Good response to dopamine
- Able to remain awake during surgery
- Able to be functional at baseline
Symptoms unresponsive to medications
- Postural instability
- Freezing
- Mental changes
- Autonomic nervous dysfunction
Proposed mechanism of FES
Improved reliance on feedforward processes - may be altering central motor control processes
Low dopamine
- Depression
- Apathy
- Anhedonia
- Anxiety
GPI vs Subthalamic Nucleus
No difference but may have a greater reduction of dosage with STN DBS